1. Home
  2. SQFT vs ARTL Comparison

SQFT vs ARTL Comparison

Compare SQFT & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQFT
  • ARTL
  • Stock Information
  • Founded
  • SQFT 1999
  • ARTL 2011
  • Country
  • SQFT United States
  • ARTL United States
  • Employees
  • SQFT N/A
  • ARTL N/A
  • Industry
  • SQFT Real Estate Investment Trusts
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQFT Real Estate
  • ARTL Health Care
  • Exchange
  • SQFT Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • SQFT 7.7M
  • ARTL 7.0M
  • IPO Year
  • SQFT 2020
  • ARTL N/A
  • Fundamental
  • Price
  • SQFT $5.59
  • ARTL $4.68
  • Analyst Decision
  • SQFT
  • ARTL Buy
  • Analyst Count
  • SQFT 0
  • ARTL 2
  • Target Price
  • SQFT N/A
  • ARTL $30.00
  • AVG Volume (30 Days)
  • SQFT 988.5K
  • ARTL 80.8K
  • Earning Date
  • SQFT 11-11-2025
  • ARTL 11-11-2025
  • Dividend Yield
  • SQFT N/A
  • ARTL N/A
  • EPS Growth
  • SQFT N/A
  • ARTL N/A
  • EPS
  • SQFT N/A
  • ARTL N/A
  • Revenue
  • SQFT $18,052,597.00
  • ARTL N/A
  • Revenue This Year
  • SQFT $23.63
  • ARTL N/A
  • Revenue Next Year
  • SQFT N/A
  • ARTL N/A
  • P/E Ratio
  • SQFT N/A
  • ARTL N/A
  • Revenue Growth
  • SQFT N/A
  • ARTL N/A
  • 52 Week Low
  • SQFT $4.19
  • ARTL $4.20
  • 52 Week High
  • SQFT $23.00
  • ARTL $28.60
  • Technical
  • Relative Strength Index (RSI)
  • SQFT 47.62
  • ARTL 36.83
  • Support Level
  • SQFT $5.20
  • ARTL $4.29
  • Resistance Level
  • SQFT $6.22
  • ARTL $4.78
  • Average True Range (ATR)
  • SQFT 0.52
  • ARTL 0.36
  • MACD
  • SQFT -0.07
  • ARTL 0.09
  • Stochastic Oscillator
  • SQFT 25.47
  • ARTL 19.25

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: